Earnings Feed
Start Free
Home/Filings/4/0000884905-12-000081
4//SEC Filing

Roberge Raymond P 4

Accession 0000884905-12-000081

CIK 0000884905other
View on SEC.govCompany Profile

Filed

Nov 27, 7:00 PM ET

Accepted

Nov 28, 2:58 PM ET

Size

18.6 KB

Accession

0000884905-12-000081

Insider Transaction Report

Form 4
Period: 2012-11-26
PRAXAIR INCPX
Roberge Raymond P
Senior Vice President
Transactions
  • Exercise/Conversion

    Common Stock

    2012-11-26$61.47/sh+12,500$768,375→ 17,170.872 total
  • Sale

    Common Stock

    2012-11-26$106.37/sh−12,500$1,329,625→ 4,670.872 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2012-11-26−12,500→ 0 total
    Exercise: $61.47From: 2008-02-27Exp: 2017-02-27→ Common Stock (12,500 underlying)
Holdings

  • Stock Option (right to buy)

    Exercise: $83.89From: 2009-02-26Exp: 2018-02-26→ Common Stock (13,700 underlying)
    13,700

  • Stock Option (right to buy)

    Exercise: $97.84From: 2012-02-22Exp: 2021-02-22→ Common Stock (19,790 underlying)
    19,790

  • Common Stock

    (indirect: By 401(k))
    70.046

  • Stock Option (right to buy)

    Exercise: $109.68From: 2013-02-28Exp: 2022-02-28→ Common Stock (21,505 underlying)
    21,505

  • Stock Option (right to buy)

    Exercise: $60.92From: 2010-02-24Exp: 2019-02-24→ Common Stock (27,090 underlying)
    27,090

  • Stock Option (right to buy)

    Exercise: $76.16From: 2011-02-23Exp: 2020-02-23→ Common Stock (20,465 underlying)
    20,465

  • Deferred Stock

    Exercise: $0.00→ Common Stock (15,346.334 underlying)
    15,346.334
Footnotes (8)
  • [F1]This total includes shares previously acquired through automatic dividend reinvestment under the Praxair Dividend Reinvestment and Stock Purchase Plan and unvested restricted stock units.
  • [F2]The $106.37 price reported is the weighted average sale price. The sale prices ranged from $106.220 to $106.498 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
  • [F3]This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
  • [F4]This option vests over three years in three consecutive equal annual installments beginning on February 23, 2011.
  • [F5]This option vests over three years in three consecutive equal annual installments beginning on February 22, 2012.
  • [F6]This option vests over three years in three consecutive equal annual installments beginning on February 28, 2013.
  • [F7]Conversion to Praxair Common Stock is on a 1-for-1 basis.
  • [F8]Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Program as amended ("Deferred Program") and are to be settled in Praxair Common Stock.

Documents

1 file

Issuer

PRAXAIR INC

CIK 0000884905

→
Entity typeother

Related Parties

1
  • filerCIK 0001548282

Filing Metadata

Form type
4
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 2:58 PM ET
Size
18.6 KB
View on SEC.gov